Clinical Trials Browser

Phase 2 × Anemia, Iron-Deficiency × Clear all

NCT06508827 2025-07-09

Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma

Phase 2 Withdrawn

Classical hematologyDermatologic

Anemia, Melanoma, Anemia, Iron-Deficiency

NCT05913414 2023-06-22

Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma

Phase 2 Recruiting

Classical hematologyHead & Neck

Nasopharyngeal Carcinoma, Anemia, Anemia, Iron-Deficiency

NCT05220800 2022-03-03

NAIDIC

Phase 2 Not yet recruiting

Classical hematologyGastrointestinal

Colorectal Neoplasms, Anemia, Iron-Deficiency

NCT02469480 2020-10-19

Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.

Phase 2 Completed

Classical hematologyGastrointestinal

Colorectal Neoplasms, Anemia, Iron-Deficiency

NCT02949947 2020-04-06

Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy

Phase 2 Terminated

3 enrolled 5 charts

Classical hematologyGastrointestinalSarcoma

Plexosarcoma, Anemia, Iron-Deficiency, Gastrointestinal Stromal Tumors